Correction: Impact of epidural analgesia on the systemic biomarker response after hepatic resection

Diego Vicente; Miguel Patino; Rebecca Marcus; Heather Lillemoe; Preparim Limani; Timothy Newhook; Andy Lee; Ching-Wei Tzeng; Yun Segraves-Chun; David Tweardy; Vijaya Gottumukkala; Jean-Nicolas Vauthey; Thomas Aloia; Juan P. Cata

doi:10.18632/oncotarget.27295

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Impact of epidural analgesia on the systemic biomarker response after hepatic resection

PDF | How to cite

Oncotarget. 2019; 10:6397-6397. https://doi.org/10.18632/oncotarget.27295

Metrics: PDF 1044 views | ?

Diego Vicente^1,2, Miguel Patino^2,4, Rebecca Marcus¹, Heather Lillemoe¹, Preparim Limani¹, Timothy Newhook¹, Andy Lee¹, Ching-Wei Tzeng¹, Yun Segraves-Chun¹, David Tweardy³, Vijaya Gottumukkala⁴, Jean-Nicolas Vauthey¹, Thomas Aloia¹ and Juan P. Cata^2,4

¹ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
² Anesthesiology and Surgical Oncology Research Group, Houston, TX, USA
³ Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
⁴ Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Published: October 29, 2019

This article has been corrected: The last name of the 4th author was spelled incorrectly. The proper spelling is given below:

Heather Lillemoe¹

Original article: Oncotarget. 2019; 10:584–594. DOI: https://doi.org/10.18632/oncotarget.26549.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27295

Publication Alerts

Corrections:

Correction: Impact of epidural analgesia on the systemic biomarker response after hepatic resection